Current Ratio of OnKure Therapeutics, Inc. from 30 Sep 2021 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
OnKure Therapeutics, Inc. quarterly Current Ratio in x history and change rate from 30 Sep 2021 to 31 Dec 2025.
- OnKure Therapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 11.04x, a 44% decline year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
OnKure Therapeutics, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 11.04x | -8.58x | -44% | 31 Dec 2025 |
| Q3 2025 | 11.08x | -7.48x | -40% | 30 Sep 2025 |
| Q2 2025 | 12.36x | -0.61x | -4.7% | 30 Jun 2025 |
| Q1 2025 | 15.31x | +4.81x | +46% | 31 Mar 2025 |
| Q4 2024 | 19.62x | +10.61x | +118% | 31 Dec 2024 |
| Q3 2024 | 18.56x | +7.9x | +74% | 30 Sep 2024 |
| Q2 2024 | 12.97x | +1.43x | +12% | 30 Jun 2024 |
| Q1 2024 | 10.5x | -2.39x | -19% | 31 Mar 2024 |
| Q4 2023 | 9.01x | -6.29x | -41% | 31 Dec 2023 |
| Q3 2023 | 10.65x | -6.57x | -38% | 30 Sep 2023 |
| Q2 2023 | 11.54x | -8.99x | -44% | 30 Jun 2023 |
| Q1 2023 | 12.9x | -13.58x | -51% | 31 Mar 2023 |
| Q4 2022 | 15.3x | -14.02x | -48% | 31 Dec 2022 |
| Q3 2022 | 17.23x | -9.28x | -35% | 30 Sep 2022 |
| Q2 2022 | 20.53x | 30 Jun 2022 | ||
| Q1 2022 | 26.48x | 31 Mar 2022 | ||
| Q4 2021 | 29.32x | 31 Dec 2021 | ||
| Q3 2021 | 26.51x | 30 Sep 2021 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.